Rapid improvement of depression and psychotic symptoms in Huntington's disease: A retrospective chart review of seven patients treated with electroconvulsive therapy

General Hospital Psychiatry

Volumn 35, Issue 6, 2013, Pages 678.e3-678.e5

  Cusin, Cristina ^a   Franco, Felipe Boschini ^b   Fernandez Robles, Carlos ^a   DuBois, Christina M ^a   Welch, Charles A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Depression; Electroconvulsive therapy; Huntington's disease; Movement disorder; Psychiatry

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CITALOPRAM; CLONAZEPAM; CLOZAPINE; DULOXETINE; ETIRACETAM; FLUOXETINE; GALANTAMINE; HALOPERIDOL; LAMOTRIGINE; LORAZEPAM; METHADONE; MILNACIPRAN; OLANZAPINE; PHENYTOIN; QUETIAPINE; RISPERIDONE; TIZANIDINE; TRAZODONE; VALPROIC ACID; ZOLPIDEM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUNTINGTON CHOREA; MALE; MEDICAL RECORD REVIEW; MENTAL PATIENT; PHYSICAL TOLERANCE; PSYCHOSIS; RISK BENEFIT ANALYSIS; TREATMENT DURATION; TREATMENT RESPONSE;

DEPRESSION; ELECTROCONVULSIVE THERAPY; HUNTINGTON'S DISEASE; MOVEMENT DISORDER; PSYCHIATRY;

ADULT; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887032790     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.01.015     Document Type: Article

References (19)

1. Genes and human disease: Huntington's disease: World Health Organization, 2012.
2. Duff K., Paulsen J.S., Beglinger L.J., et al. "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci 2010, 22(2):196-207.
3. Paulsen J.S., Nehl C., Hoth K.F., et al. Depression and stages of Huntington's disease. J Neuropsychiatry Clin Neurosci 2005, 17(4):496-502.
4. Slaughter J.R., Martens M.P., Slaughter K.A. Depression and Huntington's disease: prevalence, clinical manifestations, etiology, and treatment. CNS Spectr 2001, 6(4):306-326.
5. Epping E.A., Paulsen J.S. Depression in the early stages of Huntington disease. Neurodegener Dis Manag 2011, 1(5):407-414.
6. Walker F.O. Huntington's disease. Lancet 2007, 369(9557):218-228.
7. Bird T.D. Outrageous fortune: the risk of suicide in genetic testing for Huntington disease. Am J Hum Genet 1999, 64(5):1289-1292.
8. Phillips W., Shannon K.M., Barker R.A. The current clinical management of Huntington's disease. Mov Disord 2008, 23(11):1491-1504.
9. Bonelli R.M., Wenning G.K., Kapfhammer H.P. Huntington's disease: present treatments and future therapeutic modalities. Int Clin Psychopharmacol 2004, 19(2):51-62.
10. Ranen N.G., Peyser C.E., Folstein S.E. ECT as a treatment for depression in Huntington's disease. J Neuropsychiatry Clin Neurosci 1994, 6(2):154-159.
11. Lewis C.F., DeQuardo J.R., Tandon R. ECT in genetically confirmed Huntington's disease. J Neuropsychiatry Clin Neurosci 1996, 8(2):209-210.
12. Beale M.D., Kellner C.H., Gurecki P., Pritchett J.T. ECT for the treatment of Huntington's disease: a case study. Convuls Ther 1997, 13(2):108-112.
13. van Duijn E., Roos R.A., Smarius L.J., van der Mast R.C. Electroconvulsive therapy in patients with Huntington's disease and depression. Ned Tijdschr Geneeskd 2005, 149(39):2141-2144.
14. Rittmannsberger H., Gebetsberger B., Pichler R., et al. A case of affective disorder with psychotic symptoms as late manifestation of Huntington's Chorea. Psychiatr Prax 2011, 38(6):306-308.
15. Zwil A.S., Pelchat R.J. ECT in the treatment of patients with neurological and somatic disease. Int J Psychiatry Med 1994, 24(1):1-29.
16. Holl A.K., Wilkinson L., Painold A., Holl E.M., Bonelli R.M. Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR. Int Clin Psychopharmacol 2010, 25(1):46-50.
17. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003, 361(9360):799-808. UK ECT Review Group.
18. Verwijk E., Comijs H.C., Kok R.M., et al. Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review. J Affect Disord 2012, 140(3):233-243.
19. Nasreddine Z.S., Phillips N.A., Bedirian V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53(4):695-699.